David Jensen

Writing from the perspective of more than three decades in the news business, Jensen brings a background in business and government to bear on the $3 billion California stem cell agency. Now retired, his career included a 10-year stint as executive business editor of The Sacramento Bee, legislative coverage for United Press International and two years as a press aide to Gov. Jerry Brown during his first term in office. Jensen has covered the stem cell agency since its inception from his sailboat/home located south of the border with visits to California from time to time.

Web Site: http://californiastemcellreport.blogspot.com/


Conflict-of-Interest Failings Reported in Application Reviews at California Stem Cell Agency

May 17, 2015

Conflict-of-interest issues have dogged the $3 billion California stem cell agency since its inception, and they are surfacing once again this week in a report commissioned by the agency itself.This time the matter is being brought up by Moss-Adams, LL...

California Stem Cell Agency to Hire Top VP

May 17, 2015

Randy Mills, who enters his second year this week as president of the California stem cell agency, is looking for a vice president for the $3 billion research enterprise. The salary for the new executive ranges up to $375,524. He or she would be t...

Business-friendly Changes in California’s $500 Million Stem Cell Loan Program

May 14, 2015

The California stem cell agency is set to overhaul its $500 million loan program, acknowledging that it has been far less than successful.

The change would allow companies to accept a multimillion dollar grant and then convert it to a loan. The process would enable a firm to escape paying royalties on a lucrative product...

Fast-Track Stem Cell Grants and Big Boost in California Stem Cell Agency Budget

May 12, 2015

Directors of the California stem cell agency will meet May 21 to make their first award under the agency's new, fast-track grant program and to approve an $18.7 million operational budget, up $2.8 million from this year's estimated spending.

The award will come in Randy Mills' CIRM 2.0 program as he begins his second year...

jCyte to Conduct Clinical Trial on Stem Cell Therapy for Retinitis Pigmentosa

May 8, 2015
jCyte to Conduct Clinical Trial on Stem Cell Therapy for Retinitis Pigmentosa

More information is emerging today on the clinical trial for a retinal eye disease supported by the California stem cell agency, which has already committed $20 million or so to the project.Henry Klassen and Jing YangThe trial will be conducted by jCyt...

12th Clinical Trial For California’s Stem Cell Agency

May 7, 2015

The California stem cell agency today announced its 12th clinical trial, one that deals with retinal eye problems and and research that has already seen $21 million in state funding. 

The trial involves work by Henry Klassen of UC Irvine, where the treatments will be carried out pending final approval by the school's insitutional review...

California’s ‘Incredible’ Stem Cell Invention

Apr 16, 2015

<iframe src="https://player.vimeo.com/video/125059373" width="500" height="281" frameborder="0" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe> <p><a href="https://vimeo.com/125059373">C. Randal Mills - CIRM 2.0. Building a better stem cell agency (Part 2)</a> from <a href="https://vimeo.com/mccindustryrelations3">MCC Industry Relations</a> on <a href="https://vimeo.com">Vimeo</a>.</p>
Randy Mills, the president of the $3 billion California stem cell agency, was selling hard a couple of months ago in San Diego....

‘Born in Hype:’ The California Experiment and Stem Cell Research

Apr 2, 2015

A California newspaper with a daily readership of 1.5 million this week thrashed the field of stem cell science, declaring that it “is slathered with so much money that immoderate predictions of success are common.”


“Infected with hype” is the way the headline put it on the March 31 piece in the Los Angeles Times....

‘Born in Hype:’ The California Experiment and Stem Cell Research

Apr 2, 2015

A California newspaper with a daily readership of 1.5 million this week thrashed the field of stem cell science, declaring that it “is slathered with so much money that immoderate predictions of success are common.”


“Infected with hype” is the way the headline put it on the March 31 piece in the Los Angeles Times....

Moratorium on Possible Genetic Alteration of Human Race on Agenda Tomorrow at California Stem Cell Agency

Apr 1, 2015

The select panel that helps the $3 billion California stem cell agency set  research standards meets tomorrow and Friday in Los Angeles, its first session since 2013.


The agenda appears modest but it does include a discussion involving possible genetic modifications to the human race and the germ line letter signed by...

Stay connected to Sacramento Connect

Follow Sacramento Connect on Twitter  Find Sacramento Connect on Facebook

Advertisement

Categories

  • Hot Topics (2)
  • Shopping (822)
  • Top Stories (3595)

Advertisement